Fundz

Rani Therapeutics Appoints Jesper Høiland as Head of Strategy

PUBLIC · RANIMar 25, 2026

Position

Head of Strategy

Company

Rani Therapeutics Holdings

Jesper Høiland
San JoseBiotechnologyHealth CareTherapeuticsBiopharma

Description

Rani Therapeutics announced the appointment of Jesper Høiland as Head of Strategy. He will be responsible for shaping the company's corporate and pipeline strategy, aligning development decisions with strategic and market considerations.

Quick answer

Rani Therapeutics Appoints Jesper Høiland as Head of Strategy (March 25, 2026). Rani Therapeutics Holdings is based in San Jose, California, United States.

Who is the new Head of Strategy at Rani Therapeutics Holdings?
Rani Therapeutics Holdings named Jesper Høiland Head of Strategy, announced March 25, 2026.
What did Rani Therapeutics Holdings announce on March 25, 2026?
Rani Therapeutics announced the appointment of Jesper Høiland as Head of Strategy. He will be responsible for shaping the company's corporate and pipeline strategy, aligning development decisions with strategic and market considerations.
What does Rani Therapeutics Holdings do?
Rani Therapeutics Holdings, Inc. is a biotechnology company that focuses on developing and commercializing oral therapeutics using its proprietary RaniPill™ platform.
Where is Rani Therapeutics Holdings based?
Rani Therapeutics Holdings is based in San Jose, California, United States.
Which similar companies made leadership changes around the same time?
Aurinia Pharma (March 23, 2026), Aquestive Therapeutics, Inc. (March 20, 2026), Atossa Therapeutics (March 19, 2026) and IsomAb (March 18, 2026) also announced leadership changes within 45 days of Rani Therapeutics Holdings.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biopharma

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Rani Therapeutics Holdings, and when

A new leader at Rani Therapeutics Holdings brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Rani Therapeutics Holdings raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Rani Therapeutics Holdings, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Rani Therapeutics Holdings. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Rani Therapeutics Holdings

Location

San Jose, California, United States

About

Rani Therapeutics Holdings, Inc. is a biotechnology company that focuses on developing and commercializing oral therapeutics using its proprietary RaniPill™ platform. This platform enables the delivery of biologic medicines to patients in a non-invasive way, thereby improving patient compliance and outcomes. The company primarily specializes in the development of therapies for chronic diseases and employs advanced technology for drug formulation. Based in San Jose, California, Rani Therapeutics is publicly traded on The Nasdaq Stock Market under the symbol 'RANI'. The company is recognized as an emerging growth company, indicating its strategic focus on innovative solutions in the biopharmaceutical industry.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Rani Therapeutics Holdings changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Rani Therapeutics Holdings's next move

Learn about Strategic plan

Rani Therapeutics Holdings changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.